NCT04741386View on ClinicalTrials.gov

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

CompletedOBSERVATIONAL
Enrollment

854

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

June 4, 2021

Study Completion Date

February 25, 2022

Conditions
Covid19Chronic Kidney Diseases
Interventions
BIOLOGICAL

SARS-CoV-2 vaccination

All participants will receive two vaccinations against COVID-19 according to the manufacturer's instructions.

Trial Locations (4)

6525 GA

Radboud university medical center, Nijmegen

1105 AZ

Amsterdam University Medical Center, Amsterdam

3015 GD

Erasmus Medical Center, Rotterdam

9713 GZ

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

University Medical Center Groningen

OTHER